As of December 2025 Genmab has a market cap of NZ$33.35 Billion. This makes Genmab the world's 1147th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 10th, 2025 the market cap of Genmab was reported to be: